Effectiveness of XBB.1.5 Vaccines Against Symptomatic SARS-CoV-2 Infection in Older Adults During the JN.1 Lineage-Predominant Period, European VEBIS Primary Care Multicentre Study, 20 November 2023-1 March 2024
在 JN.1 谱系占主导地位的时期，XBB.1.5 疫苗对老年人有症状的 SARS-CoV-2 感染的有效性：欧洲 VEBIS 初级保健多中心研究，2023 年 11 月 20 日至 2024 年 3 月 1 日
期刊:Influenza and Other Respiratory Viruses
影响因子:4.2
doi:10.1111/irv.70009
Merdrignac, Lore; Laniece Delaunay, Charlotte; Verdasca, Nuno; Vega-Piris, Lorena; O'Donnell, Joan; Sève, Noémie; Trobajo-Sanmartín, Camino; Buda, Silke; Hooiveld, Mariëtte; Rodrigues, Ana Paula; Túri, Gergő; Latorre-Margalef, Neus; Mlinarić, Ivan; Lazar, Mihaela; Maurel, Marine; Castrillejo, Daniel; Bennett, Charlene; Rameix-Welti, Marie-Anne; Martínez-Baz, Iván; Dürrwald, Ralf; Meijer, Adam; Melo, Aryse; Oroszi, Beatrix; Hagey, Tove Samuelsson; Kurečić Filipović, Sanja; Dijkstra, Frederika; Gomez, Veronica; Bacci, Sabrina; Kaczmarek, Marlena; Kissling, Esther
